Home » Newsletters » BioWorld

BioWorld

Jan. 27, 1992

View Archived Issues

BLOOD VIRUS ELIMINATION PROJECT ABORTED

BIOSYS FILES FOR 2.3 MILLION-SHARE IPO

HYBRIDON PATENT FOR ANTISENSE COMPOUND

SBIR FOR PROTEASE ENZYME INHIBITORS

APPOINTMENTS AND ADVANCEMENTS

VERTEX SBIR FOR CRYSTALIZED ENZYMES

ENZON TO CO-DEVELOP CANCER TREATMENT

PROTEIN POLYMER RAISES $9.4M IN IPO

FEVERISH IPO WEEK CLOSES ON TARGET

DEPRENYL BOARD RECOMMENDS STOCK SPLIT